Researchers develop potential therapeutic model for Parkinson’s disease

Parkinson's disease (PD) is the second most common neurodegenerative disorder, implicating 10 million people worldwide b...

February 12, 2019 | Tuesday | News
Duke-NUS researchers reveal novel immune study on dengue

Researchers at Duke-NUS Medical School have demonstrated for the first time a physical interaction between two types of ...

February 8, 2019 | Friday | News
NUS researchers study nanoparticles’ role in cancer metastasis

Nanoparticles can be found in processed food (e.g. food additives), consumer products (e.g. sunscreen) and even in medic...

February 4, 2019 | Monday | News
Researchers in Japan develop strategy to strengthen skeletal muscles

Hokkaido University researchers have developed a strategy to fabricate materials that become stronger in response to mec...

February 1, 2019 | Friday | News
Alvotech raises $300mn to further biosimilar development

Alvotech has successfully raised US$300 million through a private bond offering. Net proceeds from the capital raised ...

January 24, 2019 | Thursday | News
Novel device by NUS aids in muscle recovery

A team of NUS researchers has developed a novel medical device capable of harnessing a magnetic field to make muscle reh...

January 24, 2019 | Thursday | News
I-Mab Biopharma gets USFDA IND nod for antibody TJD5

China-based clinical stage biopharmaceutical company, I-Mab Biopharma, exclusively focused on the development of innovat...

January 23, 2019 | Wednesday | News
Mechanical stress may affect normal bone development

The bone matrix contains various proteins, namely, collagen and other non-collagenous proteins. Osteoblasts are responsi...

January 21, 2019 | Monday | News
Branched-Chain amino acids can regulate progression of Cancer: Research

Researchers at A*STAR's Singapore Bioimaging Consortium (SBIC) have discovered that branched-chain amino acids (BCAAs) i...

January 21, 2019 | Monday | News
Ribon Therapeutics raises $65M

Ribon Therapeutics, a biotechnology company developing first-in-class therapeutics targeting novel enzyme families activ...

January 7, 2019 | Monday | News
Tizona Therapeutics appoints Scott Clarke as CEO

US based biotech company, Tizona Therapeutics has announced that Scott Clarke has joined the company as its chief execut...

January 5, 2019 | Saturday | News
Betta Pharma uses ProBioGen's technology for cancer treatment

ProBioGen AG, a premier service & technology provider for complex therapeutic antibodies and glycoproteins, announce...

January 3, 2019 | Thursday | News
Roswell Biotech secures $32 million series A financing round

Roswell Biotechnologies, Inc., the pioneer in the development of a molecular electronics platform for DNA Sequencing, ha...

January 3, 2019 | Thursday | News
Innovent, Eli Lilly announce co-development of Tyvyt

Innovent Biologics and Eli Lilly and Company have jointly announced that the co-developed Tyvyt (fully human anti-PD-1 t...

December 28, 2018 | Friday | News
Researchers discover new compound to treat breast cancer

A novel compound against breast cancer improves the efficacy of standard cancer treatment and shows superior tolerabilit...

December 13, 2018 | Thursday | News
Gilead names Daniel O’Day as Chairman and CEO

Gilead Sciences Inc. a research-based biopharmaceutical company that discovers, develops and commercializes innovative m...

December 11, 2018 | Tuesday | News
Trianni, MacroGenics enter into a license agreement

Trianni, Inc. and MacroGenics, Inc. has announced that they have entered into a license agreement for The Trianni Mouse,...

December 8, 2018 | Saturday | News
Australian researchers develop novel technology for cancer detection

A group of researchers from the University of Queensland, Australia has developed a new method that will enable quick an...

December 5, 2018 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls